Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-20-029596
Filing Date
2020-12-28
Accepted
2020-12-28 16:06:38
Documents
1
Period of Report
2020-12-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 3514
  Complete submission text file 0001140361-20-029596.txt   4846
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Issuer) CIK: 0001661460 (see all company filings)

EIN.: 472846548 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 614 DAVIS STREET EVANSTON IL 60201
Business Address
Corning Luke (Reporting) CIK: 0001836654 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39376 | Film No.: 201418461